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Envenomation by Bothrops species results, among other symptoms, in hemostatic dis-
turbances. These changes can be ascribed to the presence of enzymes, primarily serine
proteinases some of which are structurally similar to thrombin and speciﬁcally cleave
ﬁbrinogen releasing ﬁbrinopeptides. A rapid, three-step, chromatographic procedure was
developed to routinely purify serine proteinases from the venoms of Bothrops alternatus
and Bothrops moojeni. The serine proteinase from B. alternatus displays an apparent mo-
lecular mass of w32 kDa whereas the two closely related serine proteinases from B.
moojeni display apparent molecular masses of w32 kDa and w35 kDa in SDS–PAGE gels.
The partial sequences indicated that these enzymes share high identity with serine pro-
teinases from the venoms of other Bothrops species. These proteins coagulate plasma and
possess ﬁbrinogenolytic activity but lack ﬁbrinolytic activity.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Snake venoms are especially interesting since they
contain high concentrations of proteins and peptides that
are chemically and structurally similar to their mammalian
counterparts and which, upon envenomation, trigger a
wide spectrum of secondary effects that interfere with the
maintenance and functioning of essential biological func-
tions such as hemostasis, platelet aggregation and lipid
digestion (Lewis and Gutmann, 2004) and thus, some of, polyacrylamide gel
ases; MCD, minimum
x: þ55 17 3221 2247.
. All rights reserved.these proteins have been commercialized as diagnostic and
clinical tools (Lewis and Garcia, 2003).
Crotalidae and Viperidae proteinases (Kang et al., 2011;
Serrano, 2013; Takeda et al., 2012) are synthesized by the
exocrine venom glands and are either metalloproteinases
or serine proteinases and catalyze the cleavage of covalent
peptide bonds in proteins. Snake venom serine proteinases
(SVSPs) likely originated as digestive enzymes and subse-
quently evolved by gene duplication and sequence modi-
ﬁcations to serve other functions. SVSPs encountered in
Bothrops venoms are in many aspects functionally similar
to endogenous blood clotting enzymes and they interfere
with the maintenance and regulation of the blood coagu-
lation cascade by proteolytically cleaving speciﬁc bonds
and activating proteins involved in blood coagulation,
ﬁbrinolysis, and platelet aggregation and also in the pro-
teolytic degradation of cells resulting in an imbalance of the
hemostatic system (Kini, 2005; Serrano andMaroun, 2005).
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Bothrops species, for example two SVSPs, Bhalternin and
Balterobin have been isolated from Bothrops alternatus
venom (Costa Jde et al., 2010; Smolka et al., 1998), MSP 1,
MSP 2, MMO3 and Batroxobin have been isolated from
Bothrops moojeni venom (Oliveira et al., 1999; Serrano et al.,
1993; Stocker and Barlow, 1976) and serine proteinases
have been identiﬁed in the venoms of Bothrops jararacussu
(Bortoleto et al., 2002; Hill-Eubanks et al., 1989), Bothrops
atrox (Itoh et al., 1987; Kirby et al., 1979; Petretski et al.,
2000), Bothrops jararaca (Mandelbaum and Henriques,
1964; Nishida et al., 1994; Serrano et al., 1995). The amino
acid sequence homology shared between the SVSPs
mentioned above is approximately 65%, however, the ho-
mology exhibited by these enzymes with mammalian
serine proteinases such as thrombin and trypsin, ranges
from 30% to 40%. SVSPs are structurally similar to the
chymotrypsin family of proteinases, consist of approxi-
mately 232 amino acids and are made up of two homolo-
gous domains each containing a six-stranded b-barrel, the
overall structures and the relative orientations of the three
amino acids forming the catalytic triad, His57-Asp102-
Ser195 are strictly conserved (Barrett and Rawlings, 1995;
de Giuseppe et al., 2013). However, unique to SVSPs is an
extended C-terminal domain which is stabilized by a
disulphide bridge and is considered important for struc-
tural stability and allosteric regulation (Murakami and Arni,
2005). Amino acid substitutions and the positioning of
carbohydrate moieties around the entrance to the catalytic
site modulate the speciﬁcity of SVSPs, and hence SVSPs
serve as diagnostic tools and are potentially interesting for
the design of drugs aimed at reducing blood viscosity and
for the prevention of thrombus formation. Leading exam-
ples are the SVSPs Ancrod (Arwin) isolated from the
venom of Agkistrodon rodhostoma and Batroxobin (Deﬁb-
rase) from the venoms of B. moojeni and B. atrox, respec-
tively (Bell, 1997; Wang et al., 2009).
Since high-resolution X-ray diffraction studies provide
detailed information at the atomic level concerning factors
that determine the stereo-speciﬁcity of SVSPs, a rapid, puri-
ﬁcation procedure was developed to obtain milligram quan-
tities of SVSPs from the venoms of B. alternatus and B.moojeni
for structural studies. This puriﬁcation procedure can be used
to obtain serine proteinases from other snake venoms.
2. Materials and methods
2.1. Materials
Desiccated crude venoms of B. moojeni (1 g) and B.
alternatus (500 mg) were purchased from a local serpen-
tarium (SANMARO, Taquaral Ltda. São Paulo, Brazil).
Sephacryl S-100 Hiprep 16/60, ÄKTA puriﬁer and Benza-
midine Sepharose 4 Fast Flow (high sub) were obtained
from GE Healthcare, Amicon ultra concentrator 10 kDa and
Bovine ﬁbrinogenwere obtained fromMillipore and Sigma
Chemical Co. respectively.
Molecular weight standards (97 kDa Phosphorylase I,
66 kDa Albumin, 45 kDa Ovalbumin, 30 kDa Carbonic
Anhydrase, 20.1 kDa trypsin inhibitors, 14.4 kDa a-lactal-
bumin) were purchased from Amersham Biosciences.2.2. Sample preparation
Typically, samples of 250 mg of desiccated crude
venoms of either B. alternatus or B. moojeniwere solubilized
in 1.5 ml of Tris–HCl buffer (0.02 M Tris; 0.15 M NaCl, pH
8.0) and centrifuged at 10,000  g for 10 min. The clear
supernatant (approximately 1 ml) of each sample was
applied to a 16  60 Sephacryl S-100 column previously
equilibrated with 0.02 M Tris–HCl pH 8.0 buffer containing
0.15 M NaCl. The proteins were eluted at a ﬂow rate of
0.2 ml/min, and fractions of 1 ml/tube were collected.
The fractions obtained from peak 3a of the size-exclusion
chromatography step were pooled and applied onto a Ben-
zamidine Sepharose 4 Fast Flow (high sub) (5 ml bed vol-
ume) column, pre-equilibrated with 0.02 M Tris–HCl pH 8.0
containing 0.15 M NaCl, using a superloop (50 ml) at a ﬂow
rate of 0.5 ml/min. The unbound protein fractions were
eluted with the same buffer. The non-speciﬁcally bound
proteins were eluted with the aforementioned buffer which
additionally contained 0.5 M NaCl. Once the baseline had
stabilized, the tightly bound proteins were eluted by rapidly
changing the pH to 3.0 using a 0.05M glycine-HCl buffer. The
pH of the eluted samples was immediately adjusted to pH
7.0 by adding a buffer containing 1 M Tris pH 9.0.
Fractions representing peak 3b from the afﬁnity chro-
matography step were pooled and applied at a ﬂow rate of
0.5 ml/min onto a cation-exchange column (Mono S 5/
50 GL) previously equilibrated with 0.02 M pH 5.6 Na-
acetate buffer. The unbound proteins were washed out
with the same buffer and the bound protein fractions were
eluted with a buffer which additionally contained 1 M NaCl
using a non linear gradient from 0 to 100% NaCl. Fractions
of 1 ml/tube were collected and the absorbance was
monitored at 280 nm.
2.3. Eletrophoretic analysis: evaluation of purity and
determination of relative molecular mass (Mr)
Electrophoresis (Laemmli, 1970) was carried out at
25 mA and 100 V/gel in Tris–glycine buffer, pH 8.3, con-
taining 0.01% SDS. Gels were stained with Coomassie Bril-
liant Blue R-250 or with silver nitrate. Protein
concentrations were determined according to the micro-
biuret method (Itzhaki and Gill, 1964), using bovine serum
albumin as the standard.
2.4. Coagulant activities
The coagulant activity was performed qualitatively by
evaluating the coagulation of human plasma in vitro. The
minimum coagulant dose (MCD) was deﬁned as the
amount of enzyme able to clot plasma in 60 s (Theakston
and Reid, 1983). The assay was conducted in triplicate
with 200 mL of human plasma at 37 C and 0.1 mg–6 mg of
enzyme. As a control, plasma (200 mL) devoid of the
enzyme was used.
2.5. Fibrinogenolytic activities
Fibrinogenolytic activity was determined using the
method described by Edgar and Prentice (1973) with
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Samples of bovine ﬁbrinogen (20 mg) dissolved in a buffer
(0.1 M Tris–HCl pH 7.4, 0.01 M NaCl) were incubated with
different concentrations of each enzyme (0.05–1.0 mg) at
37 C for 30 min. The reaction was stopped by the addition
of a reducing buffer (10% (v/v) glycerol, 10% SDS, 5% 2-
mercaptoethanol, and 0.05% (w/v) bromophenol blue).
Fibrinogen hydrolysis was evidenced by 12% SDS–PAGE
gels.
2.6. Fibrinolytic activity
The ﬁbrinolytic activity was performed as described
by Leitao et al. (2000) with some modiﬁcations. A 0.3%
ﬁbrinogen solution was prepared in barbital buffer
(50 mM sodium barbital, 1.66 mM CaCl2, 0.68 mM
MgCl2, 94 mM NaCl, 0.02% sodium azide, pH 7.8) and
added to 0.95% agarose in barbital buffer under heating,
until the formation of a transparent colloid. Upon
cooling, the agarose solution (40 C) was added to the
solution of ﬁbrinogen (ﬁbrinogen: agarose, 1:1, v/v).
100 mL of bovine thrombin (1 mg/mL) was added to the
solution, which was then poured into a Petri plate for
clotting and ﬁbrin formation. The samples were applied
to pores in the gel at the desired concentrations (4–
64 mg) in a ﬁnal volume of 30 mL, followed by incubation
at 37 C for 24 h and subsequent measurement of the
haloes.
2.7. Proteolytic activity on casein
The experiment for proteolytic activity was carried out
by using the method described by Sant’ Ana et al. (2008)
with some modiﬁcations. Here, the pH was varied instead
of the concentration of the protein. Casein solution (1% w/
v) was prepared in different pHs (4.6, 5.4, 6.2, 7.0, 8.0, 8.6
and 10.2). The serine proteinases (1 mg/ml10 ml) were
added to this casein solution (100 ml) and incubated at 37 C
for 30 min. The reaction was stopped by adding 5% TCA
(300 ml) to this solution. The samples were maintained at
rest for 30 min and then centrifuged at 10,000  g for
10 min. The absorbance of the supernatant was measured
spectrophotometrically at 280 nm. The control experiment
was carried out using the casein solution without the
addition of serine proteinases. The caseinolytic activity was
expressed as U/mg (caseinolytic unit per milligram of
enzyme utilized). This experiment was repeated in
triplicate.
2.8. Protein identiﬁcation by mass spectrometry
After running SDS–PAGE gels, the protein bands were
excised and in-gel trypsin digestion was performed ac-
cording to Hanna et al. (2000). An aliquot (7.5 mL) of the
resulting peptide mixture was separated onto an analytical
C18 column (75 mm i.d.  100 mm) (Waters, Milford, MA)
for RP-HPLC coupled with nano-electrospray MS/MS on a
Thermo Electron LTQ XL ion-trap mass spectrometer at a
ﬂow rate of 500 nL/min. The gradient was 2–80% acetoni-
trile in 0.1% formic acid over 45 min. The instrument was
operated in the ‘top ten’ mode, in which one MS spectrumis acquired followed by MS/MS of the top ten most-intense
peaks detected. Full dynamic exclusion was used to
enhance dynamic range – one spectrum before exclusion
for 120 s. The resulting fragment spectra were processed
using the MS convert tool ProteoWizard (Kessner et al.,
2008) for database searching with Mascot (Matrix Sci-
ence, UK) search engine against the NCBI NR database
restricted to the taxa Serpents with a parent tolerance of
1.50 Da and fragment tolerance of 1.0 Da. Iodoacetamide
derivative of cysteine and oxidation of methionine were
speciﬁed in MASCOT as ﬁxed and variable modiﬁcations,
respectively. The sequence similarity and amino acids were
analyzed by alignment using BLAST (Altschul et al, 1997),
Jalview 2.8 (Waterhouse et al., 2009) and Clustal W
(Thompson et al., 1994).
3. Results
3.1. Puriﬁcation of serine proteinase
An efﬁcient protocol was developed for the rapid puri-
ﬁcation of serine proteinases from B. alternatus and B.
moojeni venoms. Using three chromatographic steps with
different strategies, highly pure serine proteinase samples
were obtained (Fig. 1).
Since the serine proteinase from B. alternatus contained
minor contaminants (molecular masses of about 40 and
60 kDa) (Fig. 2C), an additional cation-exchange chro-
matographic step was required (Fig. 2E) and the serine
proteinase, which possessed coagulant activity was detec-
ted in the ﬁrst peak (1c) and was labeled SPBA.
In the case of B. moojeni, two serine proteinases with
apparent molecular masses ofw32 kDa andw35 kDawere
detected (Fig. 2D) and were subsequently puriﬁed by
cation-exchange chromatography (Fig. 2F). The serine
proteinase with a molecular mass ofw32 kDa eluted in the
ﬁrst peak (peak 1c, weakly bound) and was labeled BM-
IIB32 kDa, whereas the serine proteinase with a molecular
mass of w35 kDa eluted in the second peak (2c) and was
labeled BM-IIB35 kDa. The purity of each enzyme was
conﬁrmed by SDS–PAGE gels (Fig. 2F) and both displayed
coagulant activities.
This procedure permitted us to obtain 12 mg of SPBA,
6 mg of BM-IIB32 kDa and 10 mg of BM-IIB35 kda from
250 mg of crude venom.
3.2. Coagulant activities
The serine proteinases isolated from B. alternatus (SPBA)
and from B. moojeni (BM-IIB34 kDa þ BM-IIB32 kDa) were
capable of clotting human plasma with MCD of 6 and 1 mg
respectively.
3.3. Fibrinogenolytic and ﬁbrinolytic activities
After incubation of ﬁbrinogen with the B. alternatus
serine proteinase (SPBA), degradation of the Aa and Bb
chains was observed (Fig. 3A). In the case of serine pro-
teinases from B. moojeni, BM-IIB32 kDa completely cleaved
both the Aa and Bb chains (Fig. 3B) whereas BM-IIB35 kDa
completely cleaved only the Aa chain and only partially
Fig. 1. Schematic of the puriﬁcation protocol developed to obtain pure samples of serine proteinases BM-IIB32 kDa, BM-II35 kDa and SPBA from B. moojeni and B.
alternatus crude venoms.
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teinases did not display ﬁbrinolytic activity on ﬁbrin clots
formed in agarose gels by the reaction of ﬁbrinogen with
thrombin after incubation for 48 h at 37 C (results not
shown).
3.4. Proteolytic activity
The proteolytic activity results indicate that the serine
proteinases isolated display maximum proteolytic activity
on casein at pH 8.6. However, they display only moderate
activity at either pH 8.0 or at pH 10.2.
3.5. Partial sequencing
The partial amino acid sequence analysis of isolated
enzymes SPBA and BM-IIB32 kDa (Table 1) and their
alignments with HS114 serine proteinases from B. jararaca
venom (Saguchi et al., 2005) revealed 100% identity (Fig. 4)
whereas, with Batroxobin (Itoh et al., 1987), HS112 (Saguchiet al., 2005), KN-BJ (Serrano et al., 1998) and PA-BJ (Serrano
et al., 1995) the identity was between 61 and 70%. The
partial sequence of BM-II35 kDa is approximately 80–85%
identical to Batroxobin, HS112 and Bothrombin (Table 2).
All partial sequences of the enzymes here isolated share
20–31% identity with Trypsin (Emi et al., 1986) and
Thrombin (MacGillivray and Davie, 1984) (Fig. 4).4. Discussion
Snake venom serine proteinases demonstrate high
substrate speciﬁcities and are capable of converting
ﬁbrinogen into ﬁbrin (thrombin-like enzymes) (Huang
et al., 1999; Matsui et al., 1998), release bradykinin from
kininogen (Nikai et al., 1998; Serrano et al., 1998), increase
capillary permeability (Sugihara et al., 1980), activate Factor
X (Hofmann et al., 1983), induce platelet aggregation
(Basheer et al., 1995; Serrano et al., 1995) and activate
prothrombin (Kitano et al., 2013) among various other
activities.
Fig. 2. Size-exclusion chromatography proﬁle of crude (A) B. alternatus and (B) B. moojeni venoms on Sephacryl S-100. Inset, silver stained gel of peak fractions.
Afﬁnity chromatography proﬁle on Benzamidine Sepharose 4 Fast Flow. (C) B. alternatus and (D) B. moojeni; green line and scale on the left indicate the relative
salt concentration. Inset, silver stained PAGE gel of corresponding peak fractions. Cation-exchange chromatographic proﬁle on Mono S 5/50 GL column (E) B.
alternatus and (F) B. moojeni; green line and scale on the left indicate the relative salt concentration. Inset, Coomassie Brilliant Blue stained gel of peak fractions.
M: Molecular weight standards; TP: Total Protein (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.).
L.M. Fernandes de Oliveira et al. / Toxicon 76 (2013) 282–290286
Fig. 3. Fibrinogenolytic activity of (A) B. alternatus, (B) B. moojeni 32 kDa and (C) B. moojeni 34 kDa serine proteinases respectively. 12% SDS–PAGE gel analysis of
bovine ﬁbrinogen degradation. 1: ﬁbrinogen (20 mg) control without serine proteinase; 2: ﬁbrinogen (20 mg) þ serine proteinase (0.05 mg); 3: ﬁbrinogen
(20 mg) þ serine proteinase (0.1 mg); 4: ﬁbrinogen (20 mg) þ serine proteinase (0.2 mg); 5: ﬁbrinogen (20 mg) þ serine proteinase (0.4 mg); 6: ﬁbrinogen
(20 mg) þ serine proteinase (0.6 mg); 7: ﬁbrinogen (20 mg) þ serine proteinase (0.8 mg); 8: ﬁbrinogen (20 mg) þ serine proteinase (1 mg); 9: serine proteinase
(0.6 mg) control without ﬁbrinogen.
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B. moojeni were isolated through a combination of three
steps – size-exclusion, afﬁnity and ion-exchange chroma-
tographies (Fig. 1).
Ohler et al. (2010) performed two-dimensional elec-
trophoresis of the venom of B. alternatus and isolated
proteins of apparent molecular masses of 30 kDa and
28 kDa and these isoforms share high sequence identity
with BthaTL, a serine proteinase present in the venom of B.
alternatus that affects the hemostatic system. We have
successfully puriﬁed and characterized the 32 kDa enzyme
referred to as SPBA, from B. alternatus venom.
The partial amino acid sequences of SPBA and its
alignment with serine proteinase HS114 of B. jararaca
(Saguchi et al., 2005) revealed 100% identity.
Several serine proteinases of molecular masses of about
30 kDa share signiﬁcant homologywith HS114 (a cDNA that
encodes an SVSP of B. jararaca) (Saguchi et al., 2005). Ac-
cording to their speciﬁcity for cleaving ﬁbrinogen chains,
the serine proteinases have been classiﬁed as a, b and g-
ﬁbrinogenases. SVSPs preferentially cleave the Bb-chain
(Herzig et al., 1970; Markland, 1998; Menaldo et al., 2012;
Vieira et al., 2004), however, some of them such as
Batroxobin from B. atrox, Bothrombin from B. jararaca,
Bhalternin from B. alternatus (Costa Jde et al., 2010; Sant’
Ana et al., 2008; Stocker and Barlow, 1976) also cleave the
Aa-chain. The SPBA enzyme isolated from B. alternatus
cleaved the Bb-chain and was also able to degrade the Aa-
chain, similar to thrombin and some SVSPs, such as
Jararacussin-I from B. jararacussu (Zaganelli et al., 1996),Table 1
Data of peptides identiﬁed by mass spectrometry.
SPBA B
Peptides AAYPELPAEYR; DLMLVR; IFCPNK; IMGWGSITPIQK;
KNDDALDKDLMLVR; LDSPVSDSEHIAPLSLPSSPPSVGSVCR;
NDDALDKDLMLVR; TNPDVPHCANINLLDDAVCR
A
LD
N
T
ID (NCBI) gi/82233395 g
Mascot score 1298 5
Protein
description
Venom serine proteinase HS114; Flags:
precursor
V
FlMOO3 from B. moojeni (Oliveira et al., 1999) and BpirSP41
from Bothrops pirajai (Menaldo et al., 2012).
Based on its enzymatic, structural and biochemical
characteristics, it can be inferred that SPBA is a serine
proteinase with signiﬁcant proteolytic activity on casein
and ﬁbrinogen. However, unlike most venom serine pro-
teinases studied (Bortoleto et al., 2002; Costa Jde et al.,
2010; Perez et al., 2008; Sant’ Ana et al., 2008), SPBA
showed low coagulant activity, with an MCD of 6 ug.
Many proteinases have been puriﬁed and characterized
from B. moojeni, for example, the clotting enzyme Batrox-
obin (Lochnit and Geyer, 1995; Stocker and Barlow, 1976),
three serine proteinases, MSP1, MSP2 (Serrano et al., 1993)
and MOO3 (Oliveira et al., 1999) and some metal-
loproteinases, such as BmMP-III (Ullah et al., 2012) and
Moojenin (de Morais et al., 2012). Through a combination
of three chromatographic steps, two serine proteinases
from the venom of B. moojeni have been isolated in this
study.
Serrano et al. (1993) isolated a serine proteinase from B.
moojeni venom named MSP1, that displayed two bands
around 32 kDa and 34 kDa. However, unlike the MSP1
which presents only traces of coagulant activity, the serine
proteinases (BM-IIB32 kDaþ BM-IIB34 kDa protein) from B.
moojeni isolated in this study induces high blood clotting
in vitro with an MCD of 1 ug. Other potent coagulant en-
zymes from Bothrops snake venom presented MCD higher
than the enzyme from B. moojeni isolated in this study,
4.1 ug (Perez et al., 2008) and 3.5 ug (Menaldo et al., 2012).
This capacity of both enzymes BM-IIB32 kDa and BM-M-IIB32 kDa BM-IIB35 kDa
AYPELPAEYR; IMGWGSITPIQK;
SPVSDSEHIAPLSLPSSPPSVGSVCR;
DDALDKDLMLVR;
NPDVPHCANINLLDDAVCR
KNVITDKDIMLIR;
NSEHIAPLSLPSNPPSVGSVCR;
NVITDKDIMLIR
i/82233395 gi/114837
88 865
enom serine proteinase HS114;
ags: precursor
Thrombin-like enzyme batroxobin
Fig. 4. The multiple sequence alignments of the partial amino acid sequences of SPBA, BM-IIB32 kDa and BM-IIB35 kDa with Batroxobin, BthaTL, HS112, HS114,
KN-BJ, PA-BJ, Bothrombin, Trypsin and Thrombin. The multiple sequence alignments were performed using the programs Jalview 2.8 (Waterhouse et al., 2009)
and Clustal W (Thompson et al., 1994). Residues forming the catalytic triad are highlighted using a dark background. References: Batroxobin (Itoh et al., 1987),
BthaTL (Vitorino-Cardoso et al., 2006), HS112 (Saguchi et al., 2005), HS114 (Saguchi et al., 2005), KN-BJ (Serrano et al., 1998), PA-BJ (Serrano et al., 1995),
Bothrombin (Nishida et al., 1994), human Trypsin (Emi et al., 1986) and Thrombin (MacGillivray and Davie, 1984).
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of their ability to form soluble, non-cross-linked clots
in vivo, thereby highlighting their clinical application as
deﬁbrinogenating agents.
High partial sequence identity (63–100%) was observed
between the two enzymes isolated from B. moojeni and the
Bothrops serine proteinase venoms compared. In addition,
BM-IIB32 kDa and BM-IIB35 kDa were able to degrade
casein and presented thrombin-like activities. Our resultsindicate that BM-IIB23 kDa enzyme from B. moojeni is an
ab-ﬁbrinogenase, and BM-IIB34 kDa is an a-ﬁbrinogenase.
We present here, a protocol to obtain milligram quan-
tities of highly pure serine proteinases suitable for struc-
tural and other biophysical and biochemical studies. The
crystal structure of Jararacussuin-I, a thrombin like enzyme
from Bothrops jararacussu, has been reported and it has
been proposed that the amino acid substitutions in the
loops surrounding the active site make this protein highly
Table 2
Percentage of identity between partial sequences of SPBA, BM-IIB32 kDa,
BM-IIB35 kDa, Trypsin, Thrombin and serine proteinase peptides from
Bothrops snake venoms.
Enzyme SPBA % BM-IIB32 kDa % BM-IIB35 kDa %
SPBA – 100 63.41
BM-IIB32 kDa 100 – 63.41
BM-IIB35 kDa 63.41 63.41 –
Batroxobin 68.13 67.86 85.37
BthaTL 61.54 61.90 68.29
HS112 65.93 65.48 82.93
HS114 100 100 63.41
KN-BJ 68.13 70.24 66.67
PA-BJ 69.23 70.24 70.73
Bothrombin 64.84 64.29 80.49
Trypsin 29.67 30.95 31.71
Thrombin 24.75 25.53 20.00
L.M. Fernandes de Oliveira et al. / Toxicon 76 (2013) 282–290 289negatively charged, a feature that may be relevant for its
macromolecular selectivity (Ullah et al., 2013). The crystal
structures of these enzymes from B. alternatus and B.
moojeni venoms which we are currently pursuing may
provide important insights into the structures, functions
and speciﬁcities of SVSPs.Acknowledgments
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